These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 25487034)
21. Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans. Broglio F; Gottero C; Prodam F; Gauna C; Muccioli G; Papotti M; Abribat T; Van Der Lely AJ; Ghigo E J Clin Endocrinol Metab; 2004 Jun; 89(6):3062-5. PubMed ID: 15181099 [TBL] [Abstract][Full Text] [Related]
22. Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency. Biller BM; Samuels MH; Zagar A; Cook DM; Arafah BM; Bonert V; Stavrou S; Kleinberg DL; Chipman JJ; Hartman ML J Clin Endocrinol Metab; 2002 May; 87(5):2067-79. PubMed ID: 11994342 [TBL] [Abstract][Full Text] [Related]
23. Combined stimulation of adrenocorticotropin and compound-S by single dose metyrapone test as an outpatient procedure to assess hypothalamic-pituitary-adrenal function. Berneis K; Staub JJ; Gessler A; Meier C; Girard J; Müller B J Clin Endocrinol Metab; 2002 Dec; 87(12):5470-5. PubMed ID: 12466339 [TBL] [Abstract][Full Text] [Related]
24. Decreased GH secretion and enhanced ACTH and cortisol release after ghrelin administration in Cushing's disease: comparison with GH-releasing peptide-6 (GHRP-6) and GHRH. Correa-Silva SR; Nascif SO; Lengyel AM Pituitary; 2006; 9(2):101-7. PubMed ID: 16832586 [TBL] [Abstract][Full Text] [Related]
25. Diagnosis of adrenal insufficiency using the GHRP-6 Test: comparison with the insulin tolerance test in patients with hypothalamic-pituitary-adrenal disease. Alaioubi B; Mann K; Petersenn S Horm Metab Res; 2010 Mar; 42(3):198-203. PubMed ID: 19946832 [TBL] [Abstract][Full Text] [Related]
26. Comparison of the low dose short synacthen test (1 microg), the conventional dose short synacthen test (250 microg), and the insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease. Abdu TA; Elhadd TA; Neary R; Clayton RN J Clin Endocrinol Metab; 1999 Mar; 84(3):838-43. PubMed ID: 10084558 [TBL] [Abstract][Full Text] [Related]
27. Effects of ghrelin, growth hormone-releasing peptide-6, and growth hormone-releasing hormone on growth hormone, adrenocorticotropic hormone, and cortisol release in type 1 diabetes mellitus. de Sá LB; Nascif SO; Correa-Silva SR; Molica P; Vieira JG; Dib SA; Lengyel AM Metabolism; 2010 Oct; 59(10):1536-42. PubMed ID: 20189610 [TBL] [Abstract][Full Text] [Related]
28. Corticotropin-releasing effect of hexarelin, a peptidyl GH secretagogue, in normal subjects pretreated with metyrapone or RU-486, a glucocorticoid receptor antagonist, and in patients with Addison's disease. Arvat E; Ramunni J; Maccagno B; Giordano R; Broglio F; Deghenghi R; Boscaro M; Ghigo E Neuroendocrinology; 1999 Sep; 70(3):200-6. PubMed ID: 10516483 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of secondary adrenal insufficiency: findings by corticotropin-releasing hormone test and magnetic resonance imaging in parallel. Lin SY; Won JG; Lee TI; Tang KT; Lin HD Zhonghua Yi Xue Za Zhi (Taipei); 2002 Apr; 65(4):156-63. PubMed ID: 12135194 [TBL] [Abstract][Full Text] [Related]
30. Correlation between plasma levels of ACTH and cortisol in basal states and during the CRH test in normal subjects and patients with hypothalamo-pituitary disorders. Bando H; Zhang CY; Takada Y; Takahashi H; Yamasaki R; Saito S Tokushima J Exp Med; 1991 Dec; 38(3-4):61-9. PubMed ID: 1668824 [TBL] [Abstract][Full Text] [Related]
31. Hypothalamic-pituitary-adrenal axis suppression in asthmatic children on inhaled and nasal corticosteroids: is the early-morning serum adrenocorticotropic hormone (ACTH) a useful screening test? Zöllner EW; Lombard C; Galal U; Hough S; Irusen E; Weinberg E Pediatr Allergy Immunol; 2011 Sep; 22(6):614-20. PubMed ID: 21797928 [TBL] [Abstract][Full Text] [Related]
32. The assessment of the hypothalamo-pituitary-adrenal axis in pituitary disease: are there short cuts? Dickstein G J Endocrinol Invest; 2003; 26(7 Suppl):25-30. PubMed ID: 14604063 [TBL] [Abstract][Full Text] [Related]
33. Assessment of hypothalamic-pituitary-adrenal (HPA) axis dysfunction: comparison of ACTH stimulation, insulin-hypoglycemia and metyrapone. Hartzband PI; Van Herle AJ; Sorger L; Cope D J Endocrinol Invest; 1988 Dec; 11(11):769-76. PubMed ID: 2852194 [TBL] [Abstract][Full Text] [Related]
34. Diagnosis of adrenal insufficiency: Evaluation of the corticotropin-releasing hormone test and Basal serum cortisol in comparison to the insulin tolerance test in patients with hypothalamic-pituitary-adrenal disease. Schmidt IL; Lahner H; Mann K; Petersenn S J Clin Endocrinol Metab; 2003 Sep; 88(9):4193-8. PubMed ID: 12970286 [TBL] [Abstract][Full Text] [Related]
35. Adrenocorticotrophic hormone (ACTH) responsiveness to ghrelin increases after 6 months of ketoconazole use in patients with Cushing's disease: comparison with GH-releasing peptide-6 (GHRP-6). Correa-Silva SR; Nascif SO; Molica P; Sá LB; Vieira JG; Lengyel AM Clin Endocrinol (Oxf); 2010 Jan; 72(1):70-5. PubMed ID: 19453623 [TBL] [Abstract][Full Text] [Related]
36. Assessment of the hypothalamo-pituitary-adrenal axis in patients treated with radiotherapy and chemotherapy for childhood brain tumor. Schmiegelow M; Feldt-Rasmussen U; Rasmussen AK; Lange M; Poulsen HS; Müller J J Clin Endocrinol Metab; 2003 Jul; 88(7):3149-54. PubMed ID: 12843158 [TBL] [Abstract][Full Text] [Related]